三超新材(300554.SZ)業績快報:2020年度淨利潤升103.26%至2003.07萬元
格隆匯 4 月 9日丨三超新材(300554.SZ)發佈2020年度業績快報,實現營業總收入2.58億元,同比增長15.02%;利潤總額2181.61萬元,同比增長126.96%;歸屬於上市公司股東淨利潤2003.07萬元,同比增長103.26%;基本每股收益0.2140元。
報吿期內,公司經營業績增加的主要原因為:金剛線產品訂單較去年同期有較大增長,新增國產設備產能逐步釋放,且通過技改,公司硅切片線的品質穩定性得到了改善,市場競爭力提升較為明顯,生產成本也有所下降,因此預計報吿期內淨利潤較去年同期增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.